Isakova T et al. found in patients with relatively preserved kidney function, GFR between 30 and 44 mL/min/1.73 m2, that high FGF23 was associated with significantly higher risk of end-stage renal disease. This evidence concerns the gene FGF23 and stage 5 chronic kidney disease.